The landscape of peptide therapy is experiencing a significant shift with the rise of AMP (Accelerated Molecule Peptide) chains. These novel compounds are engineered to rapidly penetrate biological boundaries, offering the promise for greater drug delivery and precise therapeutic impact. Early st